STEREOTAXIS INC (STXS) Stock Price, Forecast & Analysis
NYSEARCA:STXS • US85916J4094
STXS Key Statistics, Chart & Performance
The current stock price of STXS is 2.07 USD. In the past month the price decreased by -24.18%. In the past year, price decreased by -5.48%.
STXS Technical Analysis
STXS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STXS. The financial health of STXS is average, but there are quite some concerns on its profitability.
STXS Financial Highlights
Over the last trailing twelve months STXS reported a non-GAAP Earnings per Share(EPS) of -0.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -59.84% | ||
| ROE | -364.9% | ||
| Debt/Equity | 0 |
STXS Forecast & Estimates
11 analysts have analysed STXS and the average price target is 4.28 USD. This implies a price increase of 106.96% is expected in the next year compared to the current price of 2.07.
For the next year, analysts expect an EPS growth of 14.39% and a revenue growth 20.4% for STXS
STXS Ownership
STXS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.54 | 195.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.31 | 177.398B | ||
| SYK | STRYKER CORP | 25.15 | 142.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.29 | 112.294B | ||
| BDX | BECTON DICKINSON AND CO | 11.77 | 51.988B | ||
| IDXX | IDEXX LABORATORIES INC | 42.9 | 50.364B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.83 | 45.797B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 37.832B | ||
| RMD | RESMED INC | 21.1 | 37.336B | ||
| DXCM | DEXCOM INC | 28.94 | 28.187B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STXS
Company Profile
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 139 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Company Info
STEREOTAXIS INC
710 N Tucker Blvd, Ste 110
St. Louis MISSOURI 63108 US
CEO: David L. Fischel
Employees: 139
Phone: 13146786100
STEREOTAXIS INC / STXS FAQ
What does STEREOTAXIS INC do?
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 139 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
What is the stock price of STEREOTAXIS INC today?
The current stock price of STXS is 2.07 USD. The price decreased by -0.48% in the last trading session.
What is the dividend status of STEREOTAXIS INC?
STXS does not pay a dividend.
What is the ChartMill technical and fundamental rating of STXS stock?
STXS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the growth outlook for STEREOTAXIS INC?
The Revenue of STEREOTAXIS INC (STXS) is expected to grow by 20.4% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is STEREOTAXIS INC worth?
STEREOTAXIS INC (STXS) has a market capitalization of 193.17M USD. This makes STXS a Micro Cap stock.
What is the Short Interest ratio of STEREOTAXIS INC (STXS) stock?
The outstanding short interest for STEREOTAXIS INC (STXS) is 4.26% of its float.